User Tag List

Results 1 to 10 of 16

Hybrid View

  1. #1
    Established Member Feedback Score 1 (100%) Grape Ape's Avatar
    Join Date
    Nov 2012
    Posts
    718
    Mentioned
    0 Post(s)
    Tagged
    0 Thread(s)
    It's more about where it stays after the serm is discontinued, but I am glad you are feeeling better. That is the important part.

    Keep the updates coming.

  2. #2
    SwoleSource Member Feedback Score 0
    Join Date
    Nov 2012
    Location
    Canada
    Posts
    80
    Mentioned
    0 Post(s)
    Tagged
    0 Thread(s)
    I am not sure about going off Chlomid permanently - ever. It is reported to have low sides - and more and more studies are pointing to it as an effective long term treatment for hypogonadism.

    Clomiphene citrate is safe and effective for long-term management of hypogonadism.

    Moskovic DJ, Katz DJ, Akhavan A, Park K, Mulhall JP.


    Source

    Sexual & Reproductive Medicine Program, Urology Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA.


    Abstract


    OBJECTIVE:

    To assess the efficacy and safety of long-term clomiphene citrate (CC) therapy in symptomatic patients with hypogonadism (HG).

    PATIENTS AND METHODS:

    Serum T, oestradiol and luteinizing hormone (LH) were measured in patients who were treated with CC for over 12 months. Additionally, bone densitometry (BD) results were collected for all patients. Demographic, comorbidity, treatment and Androgen Deficiency in Aging Men (ADAM) score data were also recorded. Comparison was made between baseline and post-treatment variables, and multivariable analysis was conducted to define predictors of successful response to CC. The main outcome measures were predictors of response and long-term results with long-term CC therapy in hypogonadal patients.

    RESULTS:

    The 46 patients (mean age 44 years) had baseline serum testosterone (T) levels of 228 ng/dL. Follow-up T levels were 612 ng/dL at 1 year, 562 ng/dL at 2 years, and 582 ng/dL at 3 years (P < 0.001). Mean femoral neck and lumbar spine BD scores improved significantly. ADAM scores (and responses) fell from a baseline of 7 to a nadir of 3 after 1 year. No adverse events were reported by any patients.

    CONCLUSIONS:

    Clomiphene citrate is an effective long-term therapy for HG in appropriate patients. The drug raises T levels substantially in addition to improving other manifestations of HG such as osteopenia/osteoporosis and ADAM symptoms.

Tags for this Thread

Posting Permissions

  • You may not post new threads
  • You may not post replies
  • You may not post attachments
  • You may not edit your posts
  •